沃克塞洛特效应:对状细胞疾病新药的亲和力下降?
Charles T Quinn1,2, Russell E Ware1,2,3
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Pediatric blood & cancer
|December 11, 2024
概括
在全球范围内,Voxelotor (OXBRYTA) 已意外撤回. 这种突然的市场退出使患者和临床医生没有做好准备,造成了严重的痛苦,并削弱了人们对治疗连续性的信心.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 患者倡导 患者倡导
背景情况:
- 沃克塞洛托 (OXBRYTA) 是某些血液疾病的重要治疗选择.
- 这种药物的全球市场存在在停止使用之前是相当大的.
- 突然退出市场可能会严重影响患者的护理和信任.
研究的目的:
- 为了记录Voxelotor (OXBRYTA) 在全球市场的突然退出.
- 分析这种停药对医疗保健提供者和患者的直接影响.
- 突出意外戒毒所带来的挑战.
主要方法:
- 审查市场数据和有关Voxelotor的监管公告.
- 在退出后对临床和患者社区反的分析.
- 对治疗连续性和信任的影响的定性评估.
主要成果:
- 沃克塞洛托 (OXBRYTA) 于2024年9月从全球市场上撤回.
- 停产是突然的,并且缺乏对利益相关者的充分准备.
- 临床医生和患者都报告了严重的震惊,不确定性和信任丧失.
结论:
- 沃克塞洛托 (OXBRYTA) 的突然撤销突显了药物生命周期管理中的关键问题.
- 在市场退出过程中,有效的沟通和过渡策略至关重要.
- 重建信任需要透明度和对受影响患者群体的支持.
相关概念视频
Multiple Allele Traits
34.0K
The Concept of Multiple Allelism
34.0K
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
947
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
947
Dose-Response Relationship: Potency and Efficacy
4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K
Dose-Response Relationship: Selectivity and Specificity
6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K


